CoChat
Sign Up
Cited by 220Renal cell carcinoma treatmentMetabolism, Diabetes, and CancerCancer Risks and Factors

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

The role of diabetes mellitus in the aetiology of renal cell cancer

Open access
Lindblad, P., Chow, W. H., Chan, J., Bergström, A., Wolk, A., Gridley, G., McLaughlin, J. K., Nyrén, O., Adami, H. O.·1999·Diabetologia
DOI 10.1007/s001250051122
Open this paper in CoChat — free accountOpen PDF

Abstract

To investigate the relation between diabetes mellitus and the risk of renal cell cancer we carried out a population-based retrospective cohort study. Patients identified in the Swedish Inpatient Register who were discharged from hospitals with a diagnosis of diabetes mellitus between 1965 and 1983 formed a cohort of 153852 patients (80005 women and 73847 men). The cohort members were followed up to 1989 by record linkage to three nation-wide registries. Standardized incidence ratios (SIRs) and standardized mortality ratios (SMRs) were computed using age-specific sex-specific and period-specific incidence and mortality rates derived from the entire Swedish population. After exclusion of the first year of observation, a total of 267 incidences of renal cell cancer (ICD-7:180.0) occurred in diabetic patients compared with the 182.4 that had been expected. Increased risks were observed in both women (SIR = 1.7, 95% confidence interval, CI = 1.4-2.0) and men (SIR = 1.3; 95 % CI = 1.1-1.6) throughout the duration of follow-up (1-25 years). A higher risk was seen for kidney cancer (ICD-7:180) mortality (SMR = 1.9; 95% CI = 1.7-2.2, women; SMR 1.7, 95% CI = 1.4-1.9, men). In comparison with the general population, patients with diabetes mellitus have an increased risk of renal cell cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s001250051122

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 47 references

Research works printed but not linked: 1

  1. McLaughlin JK, Blot WJ, Devesa SS, Fraumeni Jr JF (1995) Renal Cancer. In: D Schottenfeld and JF Fraumeni J (eds) Cancer epidemiology and prevention, 2nd edn, Ox- ford University Press, New York, pp 1142±1155

Cited by

Sorted by citations

Related

See all

Metadata

Authors
Lindblad, P., Chow, W. H., Chan, J., Bergström, A., Wolk, A., Gridley, G., McLaughlin, J. K., Nyrén, O., & Adami, H. O.
Affiliations
  • Karolinska Institutet (SE)
  • National Cancer Institute (US)
  • Harvard University (US)
  • National Institutes of Health (US)
  • International Epidemiology Institute (US)
ORCID
Venue
Diabetologia
Publisher
Springer Science and Business Media LLC
Published
1999-01-11
Volume
42
Issue
1
Pages
107-112
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
DOI
10.1007/s001250051122
OpenAlex
W2038154508
Cited by
220
References
47
Citations by year
2025: 1 · 2024: 3 · 2023: 1 · 2022: 4 · 2021: 6 · 2020: 7 · 2019: 6 · 2018: 3 · 2017: 6 · 2016: 6 · 2015: 7 · 2014: 18 · 2013: 19 · 2012: 13
FWCI
5.76
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Diabetologia (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Cancerfonden
  • National Institutes of Health (n01cp060538-001)
  • National Cancer Institute (N01CP60538)
Topics
  • Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Oncology › Cancer Risks and Factors
Keywords
diabetes mellitus, renal cell carcinoma, kidney cancer, cancer risk, etiology, incidence, mortality, sex differences
MeSH terms
Age Factors, Aged, Carcinoma, Renal Cell, Diabetes Mellitus, Female, Humans, Inpatients, Kidney Neoplasms, Male, Middle Aged, Registries, Risk Factors, Sex Characteristics, Sweden, Cohort Studies, Incidence, Confidence Intervals, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review